2025-11-06T09:08:33-06:00 2024-12-31 521853933 JM&M 10500 LITTLE PATUXENT PARKWAY SUITE 770 COLUMBIA MD 21044 990 2024-01-01 200682634 AMERICA'S AGENDA HEALTH CARE FOR ALL AMER 2022231585 1025 CONNECTICUT AVENUE NW 907 WASHINGTON DC 20036 MARK C BLUM EXECUTIVE DIRECTOR 2022231585 2025-11-06 1 1 P01608821 4108840220 2024 2025-03-06 01:10:19Z MARK C BLUM 1025 CONNECTICUT AVENUE NW 907 WASHINGTON DC 20036 16130288 0 X WWW.AMERICASAGENDA.ORG X 2004 DE TO ORGANIZE, EDUCATE, AND BUILD CONSENSUS AMONG A WIDE RANGE OF LABOR, BUSINESS, HEALTH CARE, CITIZEN GROUPS, AND OTHER DIVERSE INTERESTS IN SUPPORT OF ADOPTION OF HEALTH CARE POLICIES THAT WILL ASSURE AFFORDABLE ACCESS TO HIGH QUALITY HEALTH CARE FOR ALL AMERICANS. 23 22 3 22 0 0 0 0 24506925 16095435 29233 34853 866 0 24537024 16130288 23696848 14877330 0 0 688902 710812 0 0 75639 404077 273859 24789827 15862001 -252803 268287 5022277 5278211 77257 63288 4945020 5214923 X TO ORGANIZE, EDUCATE, AND BUILD CONSENSUS AMONG A WIDE RANGE OF LABOR, BUSINESS, HEALTH CARE, CITIZEN GROUPS, AND OTHER DIVERSE INTERESTS IN SUPPORT OF ADOPTION OF HEALTH CARE POLICIES THAT WILL ASSURE AFFORDABLE ACCESS TO HIGH QUALITY HEALTH CARE FOR ALL AMERICANS. 0 0 15611745 14877330 16095435 DURING THE COURSE OF 2024, AMERICA'S AGENDA ("AAHCA") CONTINUED OUR ONGOING WORK TO BUILD AND STRENGTHEN BROAD CITIZEN COALITIONS THAT UNITE BUSINESSES, LABOR UNIONS, AND OTHER STAKEHOLDERS IN EFFECTIVE ADVOCACY TO ACHIEVE REFORMS THAT WILL ASSURE THAT EVERY AMERICAN HAS AFFORDABLE ACCESS TO HIGH-QUALITY HEALTHCARE. AS THE COST OF PRESCRIPTION DRUGS HAS EMERGED AS THE FASTEST-GROWING COMPONENT OF OVERALL HEALTH COSTS, AAHA HAS ADOPTED REDUCTION OF PRESCRIPTION DRUG COSTS AS A HIGH PRIORITY CONCERN AND FOCUS OF AAHCA ACTIVITY. AAHCA-ORGANIZED ADVOCACY CAMPAIGNS HAVE RESULTED IN ENACTMENT OF AMERICA'S AGENDA-DESIGNED STRATEGIES TO REDUCE PRESCRIPTION DRUG COSTS AND CAPTURE SUBSTANTIAL SAVINGS FOR PATIENTS, TAXPAYERS, STATE GOVERNMENT, AND PUBLIC EMPLOYEES IN SEVERAL STATES ACROSS THE COUNTRY. EACH OF OUR AAHCA STATE CAMPAIGNS HAS BUILT ON THE SUCCESS OF OUR POLICY INITIATIVE IN NEW JERSEY, WHERE IMPLEMENTATION OF THE AMERICA'S AGENDA-DESIGNED PUBLIC POLICY STRATEGY FOR CREATING A DYNAMICALLY COMPETITIVE MARKETPLACE FOR PHARMACY BENEFIT MANAGERS CAPTURED $2.52 BILLION IN PRESCRIPTION DRUG SAVINGS OVER 5 YEARS FOR STATE TAXPAYERS AND THE NEW JERSEY STATE EMPLOYEES HEALTH PLAN. AAHCA'S FEDERAL MEDICARE REFORM ADVOCACY INITIATIVE AIMS TO ELIMINATE PERVERSE PRESCRIPTION BENEFIT MANAGER (PBM) INCENTIVES TO PROVIDE MEDICARE PARTICIPANTS HIGHER, RATHER THAN LOWER, PRICED DRUGS AND PREVENT PBM CONFLICTS OF INTEREST THAT DRIVE COSTS HIGHER FOR AMERICA'S SENIORS.THE FOLLOWING EXAMPLES HIGHLIGHT ACCOMPLISHMENTS OF CONTINUING AAHCA ADVOCACY INITIATIVES OVER THE COURSE OF 2024: - IN COLORADO, DURING 2024, AAHCA EXPANDED OUR ADVOCACY COALITION OF COLORADO CITIZEN ORGANIZATIONS THAT HAD BUILT THE MOMENTUM LEADING TO THE 2022 ENACTMENT OF COLORADO'S COMPETITIVE PHARMACY BENEFITS MANAGER MARKETPLACE ACT. THE EXPANDED COALITION UNITED AROUND CORE PRINCIPLES FOR A BROADER PUBLIC AND PRIVATE SECTOR PRESCRIPTION DRUG MARKET REFORM WITH THE GOAL OF SUBSTANTIALLY REDUCING COST OF PRESCRIPTION DRUGS FOR PATIENTS IN ALL OF COLORADO'S PUBLIC AND PRIVATE SECTOR INSURANCE PROGRAMS BY ELIMINATING THE PRICE-INCREASING PRESCRIPTION DRUG MANAGER ("PBM") PRACTICE OF PRESCRIPTION DRUG ARBITRAGE AND BY CREATING A NEW, COMPETITIVE MARKETPLACE FOR PBM SERVICES WITH TRANSPARENT, COMPETITIVE DOLLAR-VALUE PRICING. COLORADO AAHCA COALITION ORGANIZATIONS ADVOCATED FOR THE URGENCY OF PRIORITIZING ENACTMENT OF EFFECTIVE PRESCRIPTION DRUG AFFORDABILITY REFORMS IN THE NEXT LEGISLATIVE SESSION, COMMENCING IN 2025, AND AS A RESULT OF THESE EFFORTS OVER THE COURSE OF 2024, A BIPARTISAN GROUP OF LEGISLATIVE LEADERS STEPPED FORWARD AS ADVOCATES AND PROSPECTIVE SPONSORS IN THE COLORADO LEGISLATURE.- IN MINNESOTA, AAHCA REMOBILIZED OUR ADVOCACY CAMPAIGN PARTNER ORGANIZATIONS WHO HAD WON ENACTMENT OF MINNESOTA'S 2021 PBM REVERSE AUCTION STATUTE FOR THE PURPOSE OF DEFENDING AGAINST A 2024 PBM INDUSTRY-BACKED INITIATIVE TO REXCIND THE REFORMS AFTER THEY HAD REDIRECTED TENS OF MILLIONS OF DOLLARS PER YEAR OF PBM GROSS REVENUES BACK TO SAVINGS FOR MINNESOTA TAX-PAYERS AND PUBLIC EMPLOYEE FAMILIES. DURING THE EXTENDED SESSION OF THE 2024 SESSION OF THE MINNESOTA LEGISLATURE, THE ADVOCACY AND EDUCATIONAL WORK OF AAHCA AND OUR CAMPAIGN COALITION PARTNERS ULTIMATELY SUCCEEDED IN THWARTING THE ATTEMPT TO RESCIND THR MINNESOTA'S PBM REVERSE AUCTION REFORM. - IN IOWA, AAHC, IN COORDINATION WITH OUR STATE COALITION PARTNERS, PROVIDED TECHNICAL SUPPORT AND ADVISEMENT TO OFFICERS OF THE STATE ADMINISTRATION - ALIGNED IN GOALS WITH STATE LEGISLATORS TO WHOM AAHCA HAS PROVIDED ADVISEMENT EARLIER IN 2024 - WITH A COMMON OBJECTIVE OF IMPLEMENTING A COMPETITIVE, TECHNOLOGY-ENABLED PBM REVERSE AUTION PROCESS MODELED ON AAHCA PRINCIPLES THAT HAVE CAPTURED BILLIONS OF TAXPAYER DOLLARS IN PRESCRIPTION DRUG SAVINGS FOR STATE GOVERNMENTS AND PUBLIC EMPLOYEE FAMILIES IN NEW JERSEY, COLORADO, AND MINNESOTA. - THE AAHCA COALITION FOR MEDICARE PART D PRESCRIPTION DRUG MARKET REFORMS HAS AIMED ITS FOCUS OVER THE COURSE OF 2023 AND 2024 ON REDUCING PRESCRIPTION DRUG COSTS FOR AMERICA'S SENIORS BY PROHIBITING LINKAGE OF PHARMACY BENEFIT MANAGER INCOME TO THE LIST PRICE OF PRESCRIPTION DRUGS. EXTENSIVE AAHCA ADVOCACY AND PUBLIC EDUATION OVER THE COURSE OF 2024, INCLUDING AN EXTENSIVE ONLINE PUBLIC EDUATION CAMPAIGN, CONTRIBUTED TO THE DECEMBER 2024 AGREEMENT ON A COMMON SET OF PRESCRIPTION DRUG AFFORDABILITY REFORMS BY BIPARTISAN LEADERSHIP IN BOTH THE US SENATE AND THE HOUSE OF REPRESENTATIVES. THE DECEMBER 2024 AGREEMENT WAS GROUNDED IN A SET OF BILLS ADVOCATED FOR BY AAHCA AND ADOPTED UNANIMOUSLY BY THE US SENATE FINANCE COMMITTEE, AND THE ENERGY AND COMMERCE COMMITTEE AND THE WAYS AND MEANS COMMITTEE OF THE US HOUSE OF REPRESETNATIVES. ATHOUGH THE BROADLY SUPPORTED DECEMBER 2024 PRESCRIPTION DRUG MARKET REFORMS WERE NOT ULTIMATELY VOTED UPON BEFORE CONGRESS ADJOURNED FOR ITS CHRISTMAS RECESS, THEY ARE EXPECTED PROVIDE THE FRAMEWORK FOR CONGRESSIONAL CONSIDERATION OF PRESCRIPTION DRUG AFFORDABILITY REFORM IN THE 119TH CONGRESS. 15611745 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 1 5 0 1 3 1 0 0 0 0 0 0 0 0 0 0 X 23 22 0 0 0 0 1 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 X MARK BLUM 2022231585 1025 CONNECTICUT AVENUE NW 907 WASHINGTON DC 20036 DOUGLAS DORITY PRESIDENT/CHAIR 20.00 20.00 X X 185731 0 27860 ERIC DEAN SECRETARY/TREASURER 1.00 1.00 X X 0 0 0 CHRISTOPHER BLASS DIRECTOR 2.00 X 0 0 0 CLAYOLA BROWN DIRECTOR 0.02 X 0 0 0 MATT LOEB DIRECTOR 0.02 X 0 0 0 JOSEPH HUNT DIRECTOR 1.00 1.00 X 0 0 0 MORTON BAHR DIRECTOR 0.02 X 0 0 0 JOSEPH R BOCK DIRECTOR 0.02 X 0 0 0 MARC PERRONE DIRECTOR 0.02 X 0 0 0 BERNARD TYSON DIRECTOR 1.90 X 0 0 0 CLARK MARCUS DIRECTOR 0.19 X 0 0 0 SCOTT A LAGANGA DIRECTOR 0.50 X 0 0 0 EDWARD M SMITH DIRECTOR 0.02 X 0 0 0 JANIS DI MONACO DIRECTOR 0.77 X 0 0 0 JAMES P HOFFA DIRECTOR 0.02 X 0 0 0 JAMES BOLAND DIRECTOR 0.06 X 0 0 0 CECIL E ROBERTS DIRECTOR 2.00 X 0 0 0 JACQUES LOVEALL DIRECTOR 0.19 X 0 0 0 SEAN M SPILLER DIRECTOR 1.00 X 0 0 0 MARK BLUM EXECUTIVE DIRECTOR 30.00 30.00 X 309605 0 91266 HONORABLE RICHARD GEPHARDT DIRECTOR 0.08 X 0 0 0 BRIAN KELLEY DIRECTOR 1.00 X 0 0 0 CLIFF A ROBERTSON DIRECTOR 0.38 X 0 0 0 JAMES CAHILL DIRECTOR 0.02 X 0 0 0 495336 0 119126 2 0 1 0 MICHAEL J KAPSA 2501 PORTER ST NW 916 WASHINGTON DC 20008 PROGRAM CONSULTING 187520 1 MEMBERSHIP DUES & ASSESSMENTS 541900 15782830 15782830 EDUCATION FUND REIMBURSEMENT 541610 312605 312605 16095435 34853 34853 16130288 16095435 0 34853 14875330 14875330 2000 2000 614462 430124 122892 61446 38058 26640 7612 3806 5708 3995 1142 571 19484 13639 3897 1948 33100 23170 6620 3310 1718 1718 19179 19179 162670 153061 6406 3203 5267 2449 2468 350 34 24 7 3 32108 32108 42191 42191 672 672 7256 5079 1451 726 DUES AND SUBSCRIPTIONS 2554 1788 511 255 TAXES 210 147 42 21 15862001 15611745 174617 75639 9995 13245 2124403 2292479 2874803 2960337 7758 7504 6783 6783 672 0 4646 4646 5022277 5278211 77257 63288 77257 63288 X 4945020 5214923 4945020 5214923 5022277 5278211 268287 1616 0 X 0 0 0 1 0 0 1348 1348 0 2935 2935 0 2500 2500 0 0 1 PBM ACCOUNTABILITY PROJECT 1025 CONNECTICUT AVE NW STE 907 WASHINGTON DC 20036 842122458 N/A 13202830 0 PROGRAM SUPPORT A PHILIP RANDOLPH INSTITUTE INC 815 16TH ST NW WASHINGTON DC 200064101 132548181 N/A 1670000 0 PROGRAM SUPPORT PART I, LINE 2: THE ORGANIZATION REQUIRES REPORTING OF FUNDS EXPENDED BY GRANTEES. X X 0 0 0 0 0 0 0 0 0 MARK BLUM EXECUTIVE DIRECTOR 309605 0 0 0 0 0 46441 0 44825 0 400871 0 0 0 DOUGLAS DORITY PRESIDENT/CHAIR 185731 0 0 0 0 0 27860 0 0 0 213591 0 0 0 FORM 990, PART VI, SECTION A, LINE 6 AAHCA MAY HAVE AS GENERAL MEMBERS, SUCH INDIVIDUALS WHO MEET THE SUPPORT AND/OR PARTICIPATION REQUIREMENTS ESTABLISHED BY THE BOARD OF DIRECTORS ("BOARD") FROM TIME TO TIME. GENERAL MEMBERS SHALL PARTICIPATE IN SURVEYS AUTHORIZED, AND PROVIDE ADVICE ON QUESTIONS OF ORGANIZATIONAL POLICY AS REQUESTED, BY THE BOARD. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 IS AVAILABLE TO THE OFFICERS AND BOARD MEMBERS PRIOR TO FILING. THE TREASURER, PRESIDENT AND EXECUTIVE DIRECTOR OF THE ORGANIZATION PERFORM A DETAILED REVIEW PRIOR TO FILING FORM 990, PART VI, SECTION B, LINE 12C EACH DIRECTOR SHALL (I) FULLY DISCLOSE ANY ACTUAL AND APPARENT MATERIAL CONFLICT OF INTEREST (WHICH MAY ARISE FROM FINANCIAL, FAMILY, OR ORGANIZATIONAL RELATIONSHIPS) INVOLVING AAHCA'S ASSETS OR AFFAIRS, (II) PROVIDE SUCH RELATED INFORMATION AS THE BOARD REQUIRES TO EVALUATE THE CONFLICT AND TAKE PERTINENT ACTION, (III) BE DISQUALIFIED FROM VOTING (AND PARTICIPATING IN DISCUSSIONS, IF SO REQUESTED BY THE BOARD) ON ANY PROPOSED ACTION INVOLVING, OR REMEDY FOR, THE DIRECTOR'S CONFLICT(S) OF INTEREST, AND (IV) ABIDE BY ALL LAWS, BYLAWS, AND RULES AND DECISIONS PERTAINING TO CONFLICTS ADOPTED BY THE BOARD. HOWEVER, UNLESS A DIRECTOR IS DISQUALIFIED BY LAW, BYLAW OR BOARD RESOLUTION, OR DISQUALIFIES HIMSELF OR HERSELF FROM VOTING ON A PARTICULAR MATTER, EACH DIRECTOR ATTENDING A MEETING IS ENTITLED TO VOTE ON ALL MATTERS COMING BEFORE THE BOARD. FORM 990, PART VI, SECTION B, LINE 15 COMPENSATION FOR THE PRESIDENT AND ED ARE ON BASED ON COMPARABILITY REVIEW AND APPROVED BY THE FINANCE COMMITTEE. THE LAST RAISES WERE APPROVED IN FEBRUARY 2023. THE BOARD APPOINTED COMPENSATION AND FINANCE COMMITTEE CONSISTS OF SECRETARY-TREASURER AND TWO BOARD MEMBERS. THIS COMMITTEE APPROVED COMPENSATION PACKAGES TO THE ORGANIZATION'S EMPLOYEES. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION WILL MAKE APPROPRIATE GOVERNING DOCUMENTS, POLICIES, AND FINANCIAL STATEMENTS AVAILABLE UPON REQUEST. AMERICA'S AGENDA HEALTHCARE EDUCATION FUND 1025 CONNECTICUT AVENUE NW 907 WASHINGTON DC 20036 200685396 POLICY DEV. & EDUCATION ON AFFORDABLE HIGH QUALITY HEALTHCARE DC 501(C)(3) LINE 7 N/A 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 0 AMERICA'S AGENDA HEALTHCARE EDUC FUND N 32081 COST AMERICA'S AGENDA HEALTHCARE EDUC FUND O 312605 COST AMERICA'S AGENDA HEALTHCARE EDUC FUND Q 92169 COST